N1-(5-aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide-13CD3 methanesulfonate; N1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide Methanesulfonate-13CD3; N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid Methanesulfonate-13CD3; Ba 33112-13CD3; DFOM-13CD3; DFX mesylate-13CD3; Deferoxamine B mesylate-13CD3; Deferoxamine methanesulfonate-13CD3; Deferrioxamine B methanesulfonate-13CD3; Desferal mesylate-13CD3; Desferrioxamine B mesylate-13CD3; Desferrioxamine methanesulfonate-13CD3; NSC 644468
Deferoxamine-13C2-d3 Mesylate is a fully characterized chemical compound used as a reference standard of API Deferoxamine. The standard offered is compliant with regulatory guidelines. Deferoxamine-13C2-d3 Mesylate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
